Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-09-014282
Filing Date
2009-06-19
Accepted
2009-06-19 10:06:14
Documents
2
Period of Report
2009-06-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5747
2 POWER OF ATTORNEY doc1.txt EX-24 2848
  Complete submission text file 0001127602-09-014282.txt   10483
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O NORTEL NETWORKS CORPORATION 8200 DIXIE ROAD STE 100 BRAMPTON ONTARIO A6 L6T 5P6
Business Address
STEVENSON KATHARINE BERGHUIS (Reporting) CIK: 0001232227 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 09900092